Colony-stimulating factor use in the context of refined risk and benefit assessments.

Suppr

超能文献

作者信息

Crawford Jeffrey

机构信息

Division of Medical Oncology, Duke Comprehensive Cancer Center, Durham, North Carolina 27710-0001, USA.

出版信息

Oncology (Williston Park). 2006 Apr;20(5 Suppl 4):9-10.

PMID:16736982

Abstract

摘要

相似文献

Colony-stimulating factor use in the context of refined risk and benefit assessments.

Oncology (Williston Park). 2006 Apr;20(5 Suppl 4):9-10.

Granulocyte colony-stimulating factors.

Med Lett Drugs Ther. 1991 Jun 28;33(847):61-3.

[The dilemma of stimulating factors in the recovery from chemotherapeutic neutropenia].

Rev Invest Clin. 1996 Jul-Aug;48(4):328.

The therapeutic use of hematopoietic growth factors.

J Allergy Clin Immunol. 1998 Jan;101(1 Pt 1):1-6. doi: 10.1016/S0091-6749(98)70185-X.

Myeloid growth factors.

J Natl Compr Canc Netw. 2009 Jan;7(1):64-83. doi: 10.6004/jnccn.2009.0006.

A tale of two growth factors.

Pharmacotherapy. 2006 Mar;26(3):443-4; discussion 444. doi: 10.1592/phco.26.3.443.

Interactive discussion on chemotherapy-related adverse events.

Pharmacotherapy. 2000 Jul;20(7 Pt 2):121S-125S. doi: 10.1592/phco.20.10.121s.35231.

Colony-stimulating factors in the prevention of solid tumors induced by chemotherapy in patients with febrile neutropenia.

Int J Antimicrob Agents. 1998 Apr;10(1):3-9. doi: 10.1016/s0924-8579(98)00016-8.

[Rational therapy with G-CSF and GM-CSF].

Med Klin (Munich). 1994 Aug 15;89(8):429-41.

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: double-edged swords.

J Am Coll Cardiol. 2005 Nov 1;46(9):1649-50. doi: 10.1016/j.jacc.2005.08.010.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Colony-stimulating factor use in the context of refined risk and benefit assessments.

Oncology (Williston Park). 2006 Apr;20(5 Suppl 4):9-10.

Granulocyte colony-stimulating factors.

Med Lett Drugs Ther. 1991 Jun 28;33(847):61-3.

[The dilemma of stimulating factors in the recovery from chemotherapeutic neutropenia].

Rev Invest Clin. 1996 Jul-Aug;48(4):328.

The therapeutic use of hematopoietic growth factors.

J Allergy Clin Immunol. 1998 Jan;101(1 Pt 1):1-6. doi: 10.1016/S0091-6749(98)70185-X.

Myeloid growth factors.

J Natl Compr Canc Netw. 2009 Jan;7(1):64-83. doi: 10.6004/jnccn.2009.0006.

A tale of two growth factors.

Pharmacotherapy. 2006 Mar;26(3):443-4; discussion 444. doi: 10.1592/phco.26.3.443.

Interactive discussion on chemotherapy-related adverse events.

Pharmacotherapy. 2000 Jul;20(7 Pt 2):121S-125S. doi: 10.1592/phco.20.10.121s.35231.

Colony-stimulating factors in the prevention of solid tumors induced by chemotherapy in patients with febrile neutropenia.

Int J Antimicrob Agents. 1998 Apr;10(1):3-9. doi: 10.1016/s0924-8579(98)00016-8.

[Rational therapy with G-CSF and GM-CSF].

Med Klin (Munich). 1994 Aug 15;89(8):429-41.

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: double-edged swords.

J Am Coll Cardiol. 2005 Nov 1;46(9):1649-50. doi: 10.1016/j.jacc.2005.08.010.